Tranexamic Acid in Primary Cemented Total Knee Replacement (TRANX-K)

This trial has now closed

A double blind controlled randomised trial of patients undergoing unilateral primary cemented total knee replacement. The objective is to find out whether Tranexamic acid will reduce blood loss significantly after total knee replacement when applied topically.

Inclusion Criteria

Patient Exclusions

Concomitant treatment

Permitted therapies include:

If you require any help, please contact:

Sattar Alshryda

North Tees and Hartlepool NHS Trust logo  

Randomisation service provided by: Sealed Envelope™.com